Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEK RXFP2 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., J. Pharmacol. Exp. Ther., Jan 2007; 320: 281 - 290 | Link | |||
HEK-sGC |
Human embryonic kidney cell line, stably expressing human sGC (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Meurer et al., Circ. Res., Jul 2009; 105: 33 - 41 | Link | |||
HEK-TetOn |
Human embryonic kidney cell line stably, expressing the tetracycline transactivators (TetON) | Human | urinary system | cell line | adherent | Metafectene | publication | L. Zhuang et al., Archives of Biochemistry and Biophysics, 2017, 625-626: 54-64, http://dx.doi.org/10.1016/j.abb.2017.06.002 | |||||
HEK-TetOn |
Human embryonic kidney cell line stably, expressing the tetracycline transactivators (TetON) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | F. Steinberg et al., J. Biol. Chem., Nov 2010; 285: 37704 - 37715 | Link | |||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | |||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. A. Eisinger et al., J. Biol. Chem., Dec 2009; 284: 34819 - 34828 | Link | ||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | ||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | D. A. Eisinger et al., J. Biol. Chem., Dec 2009; 284: 34819 - 34828 | Link | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/miRNA) | K2 Transfection System | publication | Z. Qian et al., Am. J. Physiol. Lung Cell Mol. Physiol., 2018, 315: L965–L976, doi:10.1152/ajplung.00224.2018 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | K. Albert et al., Mol. Therapy, 2021, 29: 9, doi.org/10.1016/j.ymthe.2021.04.035 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. M. Usmani et al., Cell. Microbiology, 2012, 14(3): 299–315, doi:10.1111/j.1462-5822.2011.01724.x | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | T. R. H. Büch et al., J. Biol. Chem., Sep 2009; 284: 26411 - 26420 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Kovalčíková et al., PhD Thesis, 2018, Univerzita Karlova | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J. Haar et al., Nucleic Acids Res., Feb 2016; 44: 1326 - 1341 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | T. Ramming, Dissertation, 2014, Universitaet Basel | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | A. V. Maganti et al., J. Biol. Chem., Apr 2015; 290: 9812 - 9822 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene PRO | publication | A. Jud et al., Oncotarget, 2017, 8 (4): 6130-6141 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Kim et al., Nature Communications, 2019, 10:4898, doi.org/10.1038/s41467-019-12910-2 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | N. Buettner et al., J. Gen. Virol., Jan 2010; 91: 220 - 227 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | L. Rampoldi et al., Hum. Mol. Genet., Dec 2003; 12: 3369 - 3384 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | D. P. Reguera et al., Cells, 2020, 9: 443, doi:10.3390/cells9020443 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |